Self-medication of achalasia with cannabis, complicated by a cannabis use disorder
Amandine Luquiens, Amine Benyamina, Henri-Jean Aubin, Hôpital Paul Brousse-Addictologie, 94804 Villejuif cedex, France
Nelson Lourenco, Service d'hépatogastroentérologie, Hôpital Saint Louis, Université Denis Diderot Paris VII, 75010 Paris, France
Author contributions: Luquiens A was involved in acquisition of data; analysis and interpretation of data; drafting of the manuscript and final approval of the version of the article to be published; Lourenco N, Benyamina A and Aubin HJ were involved in analysis and interpretation of data, making critical revisions related to important intellectual content of the manuscript and provided critical revision of the manuscript for important intellectual content and gave final approval of the version of the article to be published.
Ethics approval: Our research” Self-medication of achalasia with cannabis, complicated by a cannabis use disorder Cannabis in achalasia and manometry” was conducted in accordance with the Helsinki Declaration. We kindly ask for an exemption from providing the Institutional review board (institutional review board) statement, which cannot be available. The case report «Self-medication of achalasia with cannabis, complicated by a cannabis use disorder - Cannabis in achalasia and manometry» was written retrospectively, with the written patient’s consent. No review board is required or available in our Institution for this kind of case report, as it has no impact on the care providing process.
Informed consent: The patient gave written informed consent for publication before the study enrollment.
Conflict-of-interest: No relevant conflict of interest for Lourenco N, Aubin HJ, Benyamina A; Luquiens A requested for patent application of cannabis use in achalasia.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Amandine Luquiens, MD, Hôpital Paul Brousse, Addictologie-Addictologie, 12 avenue Paul Vaillant-Couturier, 94804 Villejuif cedex, France. firstname.lastname@example.org
Telephone: +33-14-5594018 Fax: +33-14-5593568
Received: September 23, 2014
Peer-review started: September 25, 2014
First decision: October 29, 2014
Revised: November 26, 2014
Accepted: January 8, 2015
Article in press: January 8, 2015
Published online: May 28, 2015